JOHNSON & JOHNSON INNOVATION - JJDC, INC.
Latest 13F filing data - Q2 2021
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | CVRX | 3.50M | $97.88M |
 | FATE | 3.38M | $293.27M |
 | ARWR | 3.26M | $270.06M |
 | MGTX | 2.90M | $44.93M |
 | PTGX | 2.45M | $109.92M |
 | LEGN | 1.63M | $66.88M |
 | VOR | 1.07M | $20.04M |
 | ACET | 729K | $7.50M |
 | ALDX | 395K | $4.47M |
 | CBIO | 67K | $290.00K |
 | NPCE | 55K | $1.32M |
 | LUNG | 6K | $249.00K |
CVRx, Inc.
CVRX
Shares Held
3.50M
Value
$97.88M
Fate Therapeutics, Inc.
FATE
Shares Held
3.38M
Value
$293.27M
Arrowhead Pharmaceuticals, Inc.
ARWR
Shares Held
3.26M
Value
$270.06M
MeiraGTx Holdings plc
MGTX
Shares Held
2.90M
Value
$44.93M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
2.45M
Value
$109.92M
Legend Biotech Corporation
LEGN
Shares Held
1.63M
Value
$66.88M
Vor Biopharma Inc.
VOR
Shares Held
1.07M
Value
$20.04M
Adicet Bio, Inc.
ACET
Shares Held
729K
Value
$7.50M
Aldeyra Therapeutics, Inc.
ALDX
Shares Held
395K
Value
$4.47M
Crescent Biopharma, Inc.
CBIO
Shares Held
67K
Value
$290.00K
NeuroPace, Inc.
NPCE
Shares Held
55K
Value
$1.32M
Pulmonx Corporation
LUNG
Shares Held
6K
Value
$249.00K